{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"18.500","floor":"13.700"},"ipodate":{"start":"2015-12-15 00:00:00","end":"2015-12-18 00:00:00"},"minimumcapital":"3737.00","subscribed":"1.74","marketcap":"67.60億","H_marketcap":"33.85億","pe":"39.89","codesrate":"100.00","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/01558/LTN20151215012_C.pdf","ipopricing":"15.000","resultdate":"2015-12-28 00:00:00","enddate":"2015-12-18 00:00:00","listeddate":"2015-12-29 00:00:00","issuenumber":"9013.20萬","issuenumberhK":"901.32萬","issuenumberother":"8111.88萬","grayprice":"15.00","sponsors":"中國國際金融香港證券有限公司","raisemoney":"125550.00萬","use":"1、約44.8%所得款項凈額，或約605.6百萬港元（人民幣500百萬元），用于在宜都基地三號地興建新口服制劑生產工廠；\n2、約12.6%所得款項凈額，或約170.2百萬港元（人民幣140.5百萬元），用于在宜都基地三號地興建新胰島素生產工廠；\n3、約28.2%所得款項凈額，或約354.1百萬港元（人民幣292.3百萬元），用于現有及未來產品的推廣及營銷活動，包括學術推廣、廣告及贊助、出版營銷及推廣數據、擴充及建立專門針對我們產品的隊伍以及對我們的產品進行市場調研；\n4、約10%所得款項凈額，或約125.6百萬港元（人民幣103.7百萬元）將用作營運資金及一般企業用途。","shares":200,"leadagent":"中國國際金融香港證券有限公司,工商國際金融有限公司,招銀國際融資有限公司,農銀國際融資有限公司,建銀國際金融有限公司,野村國際(香港)有限公司","bookrunners":"中國國際金融香港證券有限公司,工商國際金融有限公司,招銀國際融資有限公司,農銀國際融資有限公司,建銀國際金融有限公司,野村國際(香港)有限公司","coordinator":"中國國際金融香港證券有限公司,工商國際金融有限公司,招銀國際融資有限公司","firstDayOpen":"15.00","IsEiio":0,"Interestdays":10,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"中國國際金融香港證券有限公司","code":"E01558","name":"東陽光藥","fullname":"宜昌東陽光長江藥業股份有限公司"},"institutioninfo":{"principaloffice":"中國湖北省宜昌宜都市濱江路38號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628 ","chairman":"唐新發","secretary":"彭琪云,吳詠珊","telephone":"(86769) 8176 8886","substantialshareholders":"張中能及關連人士(50.04%),毛杰(18.02%)","principalactivities":"公司是一家專注于抗病毒、內分泌及代謝類疾病、心血管疾病等治療領域產品開發、生產及銷售的中國制藥企業。","website":"http://www.hec-changjiang.com"},"managerinfo":[],"investorinfo":[{"institutionname":"三星電氣(香港)有限公司","shareholding":"15,503,000.0","percentage":3.4,"ReleaseDate":"2016-06-29 00:00:00","relatedparty":"寧波三星醫療電氣股份有限公司","subsidiary":["三星電氣(香港)有限公司"],"InverstorType":"公司"},{"institutionname":"Pinpoint Asset Management Limited","shareholding":"11,368,000.0","percentage":2.5,"ReleaseDate":"2016-06-29 00:00:00","relatedparty":"王強","subsidiary":["Pinpoint Asset Management Limited"],"InverstorType":"公司"},{"institutionname":"Ally Bridge LB-Sunshine Limited","shareholding":"9,312,000.0","percentage":2.1,"ReleaseDate":"2016-06-29 00:00:00","relatedparty":"Ally Bridge LB Healthcare Master Fund Limited","subsidiary":["Ally Bridge LB-Sunshine Limited"],"InverstorType":"公司"},{"institutionname":"南方龍騰基金","shareholding":"5,167,600.0","percentage":1.1,"ReleaseDate":"2016-06-29 00:00:00","relatedparty":"南方東英資產管理有限公司","subsidiary":["南方龍騰基金"],"InverstorType":"基金"}],"TotalShareholdingPercentage":9.1},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":507}